Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-08-17 | James Mitchum is being nominated to serve as a director. No compensation information is provided for Mr. Mitchum. |
| 2016-04-26 | James Mitchum has served as a director since September 2015. Mr. Mitchum serves as a member of the Audit and Compliance Committee. Transition Period 2015 Director Compensation: $48,705 total. |
| 2017-04-28 | James Mitchum has served as a director since September 2015. Mr. Mitchum serves as chair of the Audit and Compliance Committee. |
| 2018-01-16 | With respect to Mr. Mitchum, includes 35,000 shares of common stock subject to options that are vested, vesting, exercisable or convertible, as applicable, within 60 days of December 28, 2017 and 26,000 shares for which voting and investment power is shared with Mr. Mitchum’s spouse; |
| 2018-04-20 | James Mitchum has served as a director since September 2015. Mr. Mitchum serves as chair of the Audit and Compliance Committee. |
| 2019-04-19 | James Mitchum has served as a director since September 2015. Mr. Mitchum has served as the Chief Executive Officer of RegaloRX, a patient assistance provider, since January 2019. From September 2014 to December 2018, he served as Chief Executive Officer of Heart to Heart International, a non-profit international humanitarian organization. From March 2009 to July 2012, Mr. Mitchum served as President of the Americas for EUSA Pharma, Inc., where he oversaw the streamlining of that business as well as the development, FDA approval and successful launch of a pediatric oncology drug in 2011. From 2005 to 2008, Mr. Mitchum served as President and Chief Executive Officer of Enturia, Inc., a privately owned drug-device company, based in Kansas City. From 2003 to 2005, Mr. Mitchum served as the President and Chief Executive Officer of Sanofi-Aventis Group Japan and was Chief Executive for Aventis Pharma UK from 2000 through 2002. He served in many senior financial roles from 1985 until 1999 with HMR and predecessor companies and was the Corporate Controller for HMR from 1997 until 2000. Mr. Mitchum has also served as a director on numerous private company and organization boards. Mr. Mitchum earned an MBA in Business from the University of Tennessee in Knoxville, Tennessee and a Bachelor of Science degree in Business and Math from Milligan College in Johnson City, Tennessee. Mr. Mitchum serves as chair of the Audit and Compliance Committee. Fiscal 2018 Director Compensation: Fees Earned or Paid in Cash $60,000, Option Awards $2,624, Total $62,624. |
| 2020-04-29 | James Mitchum has served as a director since September 2015. Mr. Mitchum serves as chair of the Audit and Compliance Committee. Fiscal 2019 Director Compensation: James Mitchum - Fees Earned or Paid in Cash: $60,000, Option Awards: $735, Total: $60,735. |
| 2021-04-30 | James Mitchum has served as a director since September 2015. Mr. Mitchum has served as the Chief Executive Officer of RegaloRx, a patient assistance provider since January 2019. Mr. Mitchum serves as chair of the Audit and Compliance Committee. |
Data sourced from SEC filings. Last updated: 2025-07-01